Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Helicobacter Consortium.

Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16. Erratum in: Lancet. 2013 Apr 13;381(9874):1276.

PMID:
23158886
2.

Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China.

Qian J, Ye F, Zhang J, Yang YM, Tu HM, Jiang Q, Shang L, Pan XL, Shi RH, Zhang GX.

Helicobacter. 2012 Dec;17(6):478-85. doi: 10.1111/j.1523-5378.2012.00993.x. Epub 2012 Aug 21.

PMID:
23067317
3.

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

Liou JM, Chen CC, Chang CY, Chen MJ, Fang YJ, Lee JY, Chen CC, Hsu SJ, Hsu YC, Tseng CH, Tseng PH, Chang L, Chang WH, Wang HP, Shun CT, Wu JY, Lee YC, Lin JT, Wu MS; Taiwan Helicobacter Consortium.

J Antimicrob Chemother. 2013 Feb;68(2):450-6. doi: 10.1093/jac/dks407. Epub 2012 Oct 25.

PMID:
23099849
4.

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

Sánchez-Delgado J, Calvet X, Bujanda L, Gisbert JP, Titó L, Castro M.

Am J Gastroenterol. 2008 Sep;103(9):2220-3. doi: 10.1111/j.1572-0241.2008.01924.x. Epub 2008 Jun 28.

PMID:
18564109
5.

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.

Jafri NS, Hornung CA, Howden CW.

Ann Intern Med. 2008 Jun 17;148(12):923-31. Epub 2008 May 19. Erratum in: Ann Intern Med. 2008 Sep 16;149(6):439.

PMID:
18490667
6.

Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients.

Urgesi R, Pelecca G, Cianci R, Masini A, Zampaletta C, Riccioni ME, Faggiani R.

Can J Gastroenterol. 2011 Jun;25(6):315-8.

7.

[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].

Malfertheiner P.

Dtsch Med Wochenschr. 2013 Mar;138(13):628. doi: 10.1055/s-0032-1329041. Epub 2013 Mar 19. German. No abstract available.

PMID:
23512360
8.
9.

Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus.

Ataseven H, Demir M, Gen R.

South Med J. 2010 Oct;103(10):988-92. doi: 10.1097/SMJ.0b013e3181eea6cc. Erratum in: South Med J. 2011 Jan;104(1):75. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

PMID:
20818305
10.

Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.

Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Boscarelli G, Piscitelli D, Amoruso A, Di Leo A, Miniello VL, Francavilla A, Cavallo L, Ierardi E.

Gastroenterology. 2005 Nov;129(5):1414-9.

PMID:
16285942
11.

High eradication rates of Helicobacter pylori with a new sequential treatment.

Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, De Francesco V, Menegatti M, Tampieri A, Perna F, Rinaldi V, Perri F, Papadìa C, Fornari F, Pilati S, Mete LS, Merla A, Potì R, Marinone G, Savioli A, Campo SM, Faleo D, Ierardi E, Miglioli M, Morini S.

Aliment Pharmacol Ther. 2003 Mar 1;17(5):719-26. Erratum in: Aliment Pharmacol Ther. 2003 May 1;17(9):1205.

12.

Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.

Kwon JH, Lee DH, Song BJ, Lee JW, Kim JJ, Park YS, Kim N, Jeong SH, Kim JW, Lee SH, Hwang JH, Jung HC, Song IS.

Helicobacter. 2010 Apr;15(2):148-53. doi: 10.1111/j.1523-5378.2010.00748.x.

PMID:
20402817
13.

The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey.

Aydin A, Oruc N, Turan I, Ozutemiz O, Tuncyurek M, Musoglu A.

Helicobacter. 2009 Dec;14(6):520-4. doi: 10.1111/j.1523-5378.2009.00720.x.

PMID:
19889069
14.

Helicobacter pylori treatment: is sequential or quadruple therapy the answer?

Vakil N.

Rev Gastroenterol Disord. 2008 Spring;8(2):77-82. Review.

PMID:
18641590
15.

Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.

De Francesco V, Zullo A, Margiotta M, Marangi S, Burattini O, Berloco P, Russo F, Barone M, Di Leo A, Minenna MF, Stoppino V, Morini S, Panella C, Francavilla A, Ierardi E.

Aliment Pharmacol Ther. 2004 Feb 15;19(4):407-14.

PMID:
14871280
16.

Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.

Hassan C, De Francesco V, Zullo A, Scaccianoce G, Piglionica D, Ierardi E, Panella C, Morini S.

Aliment Pharmacol Ther. 2003 Sep 15;18(6):641-6.

17.

Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.

De Francesco V, Della Valle N, Stoppino V, Amoruso A, Muscatiello N, Panella C, Ierardi E.

Aliment Pharmacol Ther. 2004 May 1;19(9):993-8.

18.

Sequential treatment for Helicobacter pylori eradication in children.

Francavilla R, Lionetti E, Cavallo L.

Gut. 2008 Aug;57(8):1178. No abstract available.

PMID:
18628382
19.

Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection?

O'Morain CA, O'Connor JP.

Nat Clin Pract Gastroenterol Hepatol. 2009 Jan;6(1):8-9. doi: 10.1038/ncpgasthep1276. Epub 2008 Oct 7. No abstract available.

PMID:
18838974
20.

Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies.

Montalban C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Calleja JL, Bellas C.

Ann Oncol. 1997;8 Suppl 2:37-9.

PMID:
9209638

Supplemental Content

Support Center